César A. Moran

60.1k total citations
404 papers, 12.4k citations indexed

About

César A. Moran is a scholar working on Neurology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, César A. Moran has authored 404 papers receiving a total of 12.4k indexed citations (citations by other indexed papers that have themselves been cited), including 157 papers in Neurology, 149 papers in Pulmonary and Respiratory Medicine and 139 papers in Surgery. Recurrent topics in César A. Moran's work include Myasthenia Gravis and Thymoma (125 papers), Pituitary Gland Disorders and Treatments (48 papers) and Medical Imaging and Pathology Studies (48 papers). César A. Moran is often cited by papers focused on Myasthenia Gravis and Thymoma (125 papers), Pituitary Gland Disorders and Treatments (48 papers) and Medical Imaging and Pathology Studies (48 papers). César A. Moran collaborates with scholars based in United States, Japan and China. César A. Moran's co-authors include Saul Suster, Annikka Weissferdt, Michael N. Koss, Neda Kalhor, Ignacio I. Wistuba, Melissa L. Rosado-de-Christenson, Carmen Behrens, Nancy F. Fishback, Saul Suster and Stephen G. Swisher and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

César A. Moran

390 papers receiving 12.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
César A. Moran United States 61 4.4k 4.3k 4.1k 3.7k 2.7k 404 12.4k
Michael P. LaQuaglia United States 61 3.5k 0.8× 5.4k 1.2× 3.4k 0.8× 3.4k 0.9× 1.1k 0.4× 325 13.3k
Yoshihiro Matsuno Japan 59 1.8k 0.4× 5.6k 1.3× 2.0k 0.5× 5.2k 1.4× 1.9k 0.7× 381 13.0k
Meinoshin Okumura Japan 55 3.1k 0.7× 4.0k 0.9× 2.4k 0.6× 2.4k 0.7× 1.9k 0.7× 346 10.3k
Paola Collini Italy 55 1.4k 0.3× 5.5k 1.3× 1.8k 0.4× 4.9k 1.3× 694 0.3× 285 11.5k
Silvana Pilotti Italy 68 1.3k 0.3× 5.3k 1.2× 2.7k 0.6× 6.6k 1.8× 1.3k 0.5× 294 16.2k
Hisao Asamura Japan 72 1.8k 0.4× 13.3k 3.1× 2.5k 0.6× 5.4k 1.5× 2.3k 0.9× 314 18.1k
Abbas Agaimy Germany 56 1.4k 0.3× 4.3k 1.0× 5.1k 1.2× 4.1k 1.1× 1.5k 0.6× 611 12.8k
Suzanne George United States 55 1.4k 0.3× 6.8k 1.6× 2.1k 0.5× 3.7k 1.0× 695 0.3× 257 11.7k
Alan Horwich United Kingdom 45 1.1k 0.3× 5.6k 1.3× 2.4k 0.6× 2.6k 0.7× 800 0.3× 140 10.4k
Moody D. Wharam United States 53 1.5k 0.3× 5.8k 1.3× 2.1k 0.5× 2.4k 0.6× 795 0.3× 184 9.3k

Countries citing papers authored by César A. Moran

Since Specialization
Citations

This map shows the geographic impact of César A. Moran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by César A. Moran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites César A. Moran more than expected).

Fields of papers citing papers by César A. Moran

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by César A. Moran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by César A. Moran. The network helps show where César A. Moran may publish in the future.

Co-authorship network of co-authors of César A. Moran

This figure shows the co-authorship network connecting the top 25 collaborators of César A. Moran. A scholar is included among the top collaborators of César A. Moran based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with César A. Moran. César A. Moran is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Lu, et al.. (2025). Rosai-Dorfman Disease Mimicking Metastasis to the Spleen From Breast Cancer. Clinical Nuclear Medicine. 50(5). 450–451.
2.
3.
Christie, Alana, Claire Carswell, César A. Moran, et al.. (2024). Effectiveness of interventions for informal caregivers of people with end-stage chronic illness: a systematic review. Systematic Reviews. 13(1). 245–245. 2 indexed citations
4.
Weissferdt, Annikka & César A. Moran. (2023). Primary epithelioid hemangioendotheliomas and angiosarcomas of the pleura: a clinicopathological and immunohistochemical analysis of 13 cases. Human Pathology. 138. 68–75. 1 indexed citations
5.
Parra, Edwin R., Jiexin Zhang, Mei Jiang, et al.. (2023). Immune cellular patterns of distribution affect outcomes of patients with non-small cell lung cancer. Nature Communications. 14(1). 2364–2364. 22 indexed citations
6.
Xie, Yang, Wei Lü, Shidan Wang, et al.. (2018). Validation of the 12-gene Predictive Signature for Adjuvant Chemotherapy Response in Lung Cancer. Clinical Cancer Research. 25(1). 150–157. 13 indexed citations
7.
Parra, Edwin R., Carmen Behrens, Jaime Rodriguez‐Canales, et al.. (2016). Image Analysis–based Assessment of PD-L1 and Tumor-Associated Immune Cells Density Supports Distinct Intratumoral Microenvironment Groups in Non–small Cell Lung Carcinoma Patients. Clinical Cancer Research. 22(24). 6278–6289. 103 indexed citations
8.
Riquelme, Erick, Carmen Behrens, Heather Lin, et al.. (2015). Modulation of EZH2 Expression by MEK-ERK or PI3K-AKT Signaling in Lung Cancer Is Dictated by Different KRAS Oncogene Mutations. Cancer Research. 76(3). 675–685. 85 indexed citations
9.
Behrens, Carmen, Luisa M. Solis, Heather Lin, et al.. (2013). EZH2 Protein Expression Associates with the Early Pathogenesis, Tumor Progression, and Prognosis of Non–Small Cell Lung Carcinoma. Clinical Cancer Research. 19(23). 6556–6565. 123 indexed citations
10.
Wistuba, Ignacio I., Carmen Behrens, Francesca Lombardi, et al.. (2013). Validation of a Proliferation-Based Expression Signature as Prognostic Marker in Early Stage Lung Adenocarcinoma. Clinical Cancer Research. 19(22). 6261–6271. 84 indexed citations
11.
Winter, William E., et al.. (2013). Intrathyroidal Parathyroid Carcinoma: Report of an Unusual Case and Review of the Literature. SHILAP Revista de lepidopterología. 2013. 1–5. 23 indexed citations
12.
Tang, Ximing, Humam Kadara, Carmen Behrens, et al.. (2011). Abnormalities of the TITF-1 Lineage-Specific Oncogene in NSCLC: Implications in Lung Cancer Pathogenesis and Prognosis. Clinical Cancer Research. 17(8). 2434–2443. 59 indexed citations
13.
Xie, Yang, Guanghua Xiao, Kevin R. Coombes, et al.. (2011). Robust Gene Expression Signature from Formalin-Fixed Paraffin-Embedded Samples Predicts Prognosis of Non–Small-Cell Lung Cancer Patients. Clinical Cancer Research. 17(17). 5705–5714. 130 indexed citations
14.
Solis, Luisa M., Carmen Behrens, Maria Gabriela Raso, et al.. (2011). Histologic patterns and molecular characteristics of lung adenocarcinoma associated with clinical outcome. Cancer. 118(11). 2889–2899. 85 indexed citations
15.
Weissferdt, Annikka & César A. Moran. (2011). Pax8 Expression in Thymic Epithelial Neoplasms. The American Journal of Surgical Pathology. 35(9). 1305–1310. 52 indexed citations
16.
Solis, Luisa M., Carmen Behrens, Wenli Dong, et al.. (2010). Nrf2 and Keap1 Abnormalities in Non–Small Cell Lung Carcinoma and Association with Clinicopathologic Features. Clinical Cancer Research. 16(14). 3743–3753. 357 indexed citations
17.
Raso, Maria Gabriela, Carmen Behrens, Matthew H. Herynk, et al.. (2009). Immunohistochemical Expression of Estrogen and Progesterone Receptors Identifies a Subset of NSCLCs and Correlates with EGFR Mutation. Clinical Cancer Research. 15(17). 5359–5368. 134 indexed citations
18.
Prudkin, Ludmila, Carmen Behrens, Diane D. Liu, et al.. (2008). Loss and Reduction of Fus1 Protein Expression is a Frequent Phenomenon in the Pathogenesis of Lung Cancer. Clinical Cancer Research. 14(1). 41–47. 68 indexed citations
19.
Tang, Ximing, Marileila Varella‐Garcia, Ana C. Xavier, et al.. (2008). Epidermal Growth Factor Receptor Abnormalities in the Pathogenesis and Progression of Lung Adenocarcinomas. Cancer Prevention Research. 1(3). 192–200. 71 indexed citations
20.
Moran, César A. & Saul Suster. (2001). Neuroendocrine Carcinomas of the Thymus. Pathology Case Reviews. 6(2). 41–48. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael P. LaQuaglia Breakdown of academic impact, for papers by Yoshihiro Matsuno Breakdown of academic impact, for papers by Meinoshin Okumura Breakdown of academic impact, for papers by Paola Collini Breakdown of academic impact, for papers by Silvana Pilotti Breakdown of academic impact, for papers by Hisao Asamura Breakdown of academic impact, for papers by Abbas Agaimy Breakdown of academic impact, for papers by Suzanne George Breakdown of academic impact, for papers by Alan Horwich Breakdown of academic impact, for papers by Moody D. Wharam
Rankless by CCL
2026